BFO
Boston Family Office Portfolio holdings
AUM
$1.51B
This Quarter Return
+23.36%
1 Year Return
+12.61%
3 Year Return
+54.38%
5 Year Return
+90.66%
10 Year Return
+237.26%
AUM
$1.03B
AUM Growth
+$1.03B
(+21%)
Cap. Flow
-$845K
Cap. Flow
% of AUM
-0.08%
Top 10 Holdings %
Top 10 Hldgs %
28.73%
Holding
253
New
17
Increased
58
Reduced
106
Closed
9
Top Buys
| 1 |
Salesforce
CRM
|
$2.79M |
| 2 |
Adobe
ADBE
|
$2.3M |
| 3 |
RTX Corp
RTX
|
$1.59M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
$1.2M |
| 5 |
Ecolab
ECL
|
$1.17M |
Top Sells
| 1 |
SS&C Technologies
SSNC
|
$3.79M |
| 2 |
Gilead Sciences
GILD
|
$3.34M |
| 3 |
RTN
Raytheon Company
RTN
|
$2.11M |
| 4 |
Middleby
MIDD
|
$1.41M |
| 5 |
Vanguard Total International Stock ETF
VXUS
|
$1.02M |
Sector Composition
| 1 | Technology | 21.47% |
| 2 | Healthcare | 16.23% |
| 3 | Financials | 9.46% |
| 4 | Industrials | 8.37% |
| 5 | Consumer Staples | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Norfolk Southern
NSC
$62.8B
| $3.18M | 0.31% | 18,123 | – | – |
|
77
Novo Nordisk
NVO
$251B
| $3.05M | 0.3% | 46,609 -2 | -0% | -$131 |
|
78
ServiceNow
NOW
$190B
| $2.99M | 0.29% | 7,379 +276 | +4% | +$112K |
|
79
Vanguard FTSE All-World ex-US ETF
VEU
$48.6B
| $2.98M | 0.29% | 62,518 -674 | -1% | -$32.1K |
|
|
80
Gilead Sciences
GILD
$140B
| $2.97M | 0.29% | 38,605 -43,398 | -53% | -$3.34M |
|
81
Exxon Mobil
XOM
$487B
| $2.97M | 0.29% | 66,424 -2,269 | -3% | -$101K |
|
82
Parker-Hannifin
PH
$96.2B
| $2.9M | 0.28% | 15,827 | – | – |
|
83
Pfizer
PFE
$141B
| $2.82M | 0.27% | 86,257 -3,274 | -4% | -$107K |
|
84
Golar LNG
GLNG
$4.48B
| $2.8M | 0.27% | 386,916 +150,468 | +64% | +$1.09M |
|
85
Walt Disney
DIS
$213B
| $2.8M | 0.27% | 25,103 -1,484 | -6% | -$165K |
|
|
86
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $2.79M | 0.27% | 71,797 +30,989 | +76% | +$1.2M |
|
87
Vanguard Dividend Appreciation ETF
VIG
$95.4B
| $2.78M | 0.27% | 23,702 +620 | +3% | +$72.6K |
|
88
Philip Morris
PM
$260B
| $2.74M | 0.27% | 39,065 -1,650 | -4% | -$116K |
|
89
Amgen
AMGN
$155B
| $2.52M | 0.25% | 10,699 -225 | -2% | -$53.1K |
|
90
Vanguard Extended Market ETF
VXF
$23.9B
| $2.5M | 0.24% | 21,111 +4,227 | +25% | +$500K |
|
|
91
SS&C Technologies
SSNC
$21.7B
| $2.5M | 0.24% | 44,170 -67,070 | -60% | -$3.79M |
|
92
Bristol-Myers Squibb
BMY
$96B
| $2.48M | 0.24% | 42,104 -700 | -2% | -$41.2K |
|
93
Colgate-Palmolive
CL
$67.9B
| $2.46M | 0.24% | 33,611 | – | – |
|
|
94
Vanguard Total International Stock ETF
VXUS
$102B
| $2.39M | 0.23% | 48,583 -20,836 | -30% | -$1.02M |
|
95
Mondelez International
MDLZ
$79.5B
| $2.39M | 0.23% | 46,645 -155 | -0.3% | -$7.93K |
|
96
Illinois Tool Works
ITW
$77.1B
| $2.19M | 0.21% | 12,502 -130 | -1% | -$22.7K |
|
|
97
RTX Corp
RTX
$212B
| $2.14M | 0.21% | 34,768 +25,837 | +289% | +$1.59M |
|
98
iShares Core S&P Mid-Cap ETF
IJH
$100B
| $1.98M | 0.19% | 11,152 +17 | +0.2% | +$3.02K |
|
99
Qualcomm
QCOM
$173B
| $1.96M | 0.19% | 21,490 | – | – |
|
100
Alcon
ALC
$39.5B
| $1.93M | 0.19% | 33,716 +2,981 | +10% | +$171K |
|